Newsroom, your daily review

Keep up with the latest in the tableting community!


Feature article

MySTYL'One

Nov. 17, 2021

STYL'One software: new release of Analis available

STYL'One users, a new release of your software is out now!

Log in to learn about the new features integrated in Analis 2.08.5.

#release #download #analis

Publish with us!

Interesting news to share with the community?
Carried a new study out?
This newsfeed is yours, do not hesitate!

Feature article

MySTYL'One

Nov. 25, 2021

Webinar Transcript - Dry Granulation Formulation Development

The webinar, which took place on October 27th, 2021 illustrates the key principles of Dry Granulation/roll compaction in a pharmaceutical process. Hanna Lou Keizer, head of Production at G. Pohl-Boskamp in Germany, and PhD graduate from the University of Düsseldorf and Institute of Pharmaceutics and Biopharmaceutics presented her work and research on hybrid modeling of roll compaction with the STYL’One Evo, as well as case studies. The webinar concluded with a Q&A session.

Read the tra...

The webinar, which took place on October 27th, 2021 illustrates the key principles of Dry Granulation/roll compaction in a pharmaceutical process. Hanna Lou Keizer, head of Production at G. Pohl-Boskamp in Germany, and PhD graduate from the University of Düsseldorf and Institute of Pharmaceutics and Biopharmaceutics presented her work and research on hybrid modeling of roll compaction with the STYL’One Evo, as well as case studies. The webinar concluded with a Q&A session.

Read the transcript below!

 

Note: registered member of MySTYL’One can access the full video of the webinar HERE.

#webinar #'dry granulation' #transcript #'roll compaction'

Got questions? Ask your peers!

Press review

MySTYL'One

Nov. 22, 2021

Lamination of Pharmaceutical Tablets: Classification and Influence of Process Parameters

Interesting article published by the University of Bordeaux on a classification and influence of process parameters on lamination of pharmaceutical tablets.

Studies were performed on the STYL’One Evo compaction simulator, mimicking a Korsch XL 100 tableting press, at speeds of 1  rpm, 10 rpm and 60 rpm. 

The article is accessible directly until December 26th
MySTYL'One members, you can also head to the papers section!

#lamination #classification #pharmaceutical #tablets #troubleshooting ...

Interesting article published by the University of Bordeaux on a classification and influence of process parameters on lamination of pharmaceutical tablets.

Studies were performed on the STYL’One Evo compaction simulator, mimicking a Korsch XL 100 tableting press, at speeds of 1  rpm, 10 rpm and 60 rpm. 

The article is accessible directly until December 26th
MySTYL'One members, you can also head to the papers section!

#lamination #classification #pharmaceutical #tablets #troubleshooting #compression  

#Tablet #lamination #'tapered die' #precompression #compression

Press review

www.patheon.com

Nov. 8, 2021

Manufacturing Process Scale-up for Phase III: Clear Sailing or Storms Ahead?

STYL'One users are in the news!

To be found on Patheon's website, a bulletin on the importance of designing design scalability into formulations from very early on, to mitigate mitigate some of the challenges that arise in Phase III.

More info here.

Access to this document will require you to leave your contact details.



Press review

MySTYL'One

Nov. 8, 2021

Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion

This new study from the University of Minnesota and Tsinghua University in Beijing shows the development of an immediate release tablet with improved oral bioavailability thanks to an amorphous solid dispersion (ASD) of sorafenib (SOR) in hydroxypropyl methylcellulose acetate succinate (HPMC-AS), prepared by coprecipitation. Access the paper here.

#Tablet #sorafenib #'amorphous solid dispersion' #coprecipitation #'Oral Bioavailibility'

Feature article

MySTYL'One

Oct. 22, 2021

STYL'One nano software: new release available

STYL'One Nano users, a new release of your software is out now!

Log in or create your account to learn about the new features integrated in Alix V.20211015

#release #alix #download

Announcement

MySTYL'One

Oct. 4, 2021

Material Characterization On STYL'One Nano

MySTYL'One user exclusive!

Head to the bulletins section and read on how STYL’One Nano can be used to demonstrate material properties, secure formulation development and their product marketing.

#bulletin #STYL'One Nano #formulation #material properties

Call for papers

Gabrielle Dupont

Sept. 14, 2021

Publish with us!

Help us feed the Community library, by sending us your papers, posters or news on tableting.

Click here to publish with us

Feature article

Bruno Villa

Sept. 10, 2021

Dry Granulation a material sparing method

WHY IS DRY GRANULATION SO POPULAR THESE DAYS?

Granulation of pharmaceutical powder is often required to prevent segregation of the Active Pharmaceutical Ingredient (API) and/or to enhance the blend flowability, which is critical to ensure consistent tablet mass (weight) on rotary tablet presses. Dry granulation has been known for decades. The main benefit is a lower cost of operation compared to wet granulation. But most interestingly, it’s much easier to contain a roller compactor to process high potent drugs. It’s also a truly continuous process, which is a big trend these days. One have to point out that in the past decade, equipment manufacturers have introduced more instrumentation and advanced control systems, such as Gerteis or LB Bohle to name a few, allowing a more consistent density on the ribbons through a gap control loop system

#dry #granulation

Press review

MySTYL'One

Sept. 9, 2021

CDMO & CRO Outlook in 2022 and Beyond

Pharmaceutical Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organisations (CRO) have been booming in the last years, thanks to an increase in pharmaceuticals activities and booming innovations driving investors. The article describes the Outlook in 2022 and beyond. 

#CDMO #CRO

Page 1 of 5

Publish with us!